IRIS
De santis, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.792
AS - Asia 2.162
EU - Europa 1.084
AF - Africa 702
SA - Sud America 616
OC - Oceania 5
Totale 8.361
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.730
SG - Singapore 1.277
SC - Seychelles 611
BR - Brasile 530
CN - Cina 474
FI - Finlandia 224
IT - Italia 206
IE - Irlanda 154
VN - Vietnam 109
DE - Germania 97
FR - Francia 74
GB - Regno Unito 70
IN - India 66
HK - Hong Kong 65
NL - Olanda 52
NG - Nigeria 44
SE - Svezia 37
AR - Argentina 35
RU - Federazione Russa 31
MX - Messico 30
BD - Bangladesh 22
CA - Canada 22
ZA - Sudafrica 21
MK - Macedonia 20
CZ - Repubblica Ceca 19
PL - Polonia 18
JP - Giappone 16
BE - Belgio 15
EC - Ecuador 15
ID - Indonesia 15
TR - Turchia 15
IQ - Iraq 13
CO - Colombia 11
PH - Filippine 11
UZ - Uzbekistan 11
ES - Italia 10
IL - Israele 10
AT - Austria 8
LT - Lituania 8
UA - Ucraina 8
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
IR - Iran 6
MA - Marocco 6
PK - Pakistan 6
TN - Tunisia 6
AM - Armenia 5
CH - Svizzera 5
KR - Corea 5
PY - Paraguay 5
VE - Venezuela 5
AU - Australia 4
JO - Giordania 4
PE - Perù 4
PT - Portogallo 4
AZ - Azerbaigian 3
EG - Egitto 3
KE - Kenya 3
LB - Libano 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BW - Botswana 2
DK - Danimarca 2
DM - Dominica 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
MY - Malesia 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
NZ - Nuova Zelanda 1
SN - Senegal 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 8.361
Salva come PNG Salva come JPEG
Città #
Chandler 665
Dallas 497
Singapore 427
The Dalles 319
Ashburn 263
Shanghai 254
Helsinki 223
Boardman 188
Wilmington 175
Dublin 154
New York 154
Beijing 99
San Mateo 77
Los Angeles 75
Hong Kong 64
Paris 58
Ann Arbor 46
Sassari 45
Milan 44
Amsterdam 43
São Paulo 43
Ho Chi Minh City 42
Benin City 41
London 37
Lawrence 35
Princeton 35
Leawood 31
Pune 29
Council Bluffs 26
Santa Clara 26
Naples 25
Hanoi 22
Woodbridge 20
Chennai 19
Columbus 19
Phoenix 19
Brno 17
Munich 17
Seattle 17
Assago 16
Belo Horizonte 15
Boston 15
Brussels 15
Fairfield 13
San Francisco 13
Stockholm 13
Tokyo 12
Warsaw 12
Brooklyn 11
Curitiba 11
Mexico City 11
Rio de Janeiro 11
Brasília 10
Tashkent 10
Moscow 9
San Jose 9
Skopje 9
Buenos Aires 8
Johannesburg 8
Montreal 8
Porto Alegre 8
Da Nang 7
Dhaka 7
Frankfurt am Main 7
Houston 7
Toronto 7
Aurora 6
Bogotá 6
Kocaeli 6
Orem 6
Quito 6
Rome 6
San Diego 6
Bitola 5
Biên Hòa 5
Campo Grande 5
Charlotte 5
Falkenstein 5
Goiânia 5
Guayaquil 5
Haiphong 5
Jakarta 5
Jundiaí 5
Manaus 5
Mumbai 5
Poplar 5
Redwood City 5
Salvador 5
Secaucus 5
West Jordan 5
Yerevan 5
Abbiategrasso 4
Amman 4
Atlanta 4
Chicago 4
Denver 4
Diadema 4
Feira de Santana 4
Hangzhou 4
Hanover 4
Totale 4.840
Salva come PNG Salva come JPEG
Nome #
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 674
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 184
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy 116
Personalized medicine in rheumatology : the paradigm of serum autoantibodies 109
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 104
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population 103
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 93
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 92
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 90
Additional organs involved in antiphospholipid syndrome : eye, ear-nose-throat, lung, gastroenteric system, endocrine glands 89
5 reasons to encourage anti-SARS-CoV-2 vaccination in patients with rheumatic diseases 88
X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma 88
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies 86
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction 86
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review 84
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 79
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 78
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 77
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 77
Liver involvement in subjects with rheumatic disease 76
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease 76
Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study' 73
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis 73
Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis 71
Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis 71
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 71
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 69
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis : a Critical Review 67
Liver abnormalities in connective tissue diseases 65
Autoantibodies and organ involvement in systemic sclerosis 64
Analysis of interstitial lung involvement in a cohort of 100 patients with systemic sclerosis. Prevalence of alveolitis detected by bronchoalveolar lavage and HRCT 64
T-Cell response to carbamylated and citrullinated collagen epitopes in patients with rheumatoid arthritis carrying DRβ1*04 64
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 63
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 63
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. 63
Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis 62
Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement 61
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 60
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis 59
B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial 57
Artriti infettive 56
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 56
The role of Wnt pathway in the pathogenesis of OA and its potential therapeutic implications in the field of regenerative medicine 56
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 56
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al 55
Type III interferons disrupt the lung epithelial barrier upon viral recognition 55
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement 55
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 53
Tumori ossei 52
The elegance of a macrophage 52
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 51
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 51
Viral Respiratory Pathogens and Lung Injury 51
The autoinflammatory side of systemic sclerosis 51
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients 51
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 51
Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency 50
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids 50
BAFF and rheumatic autoimmune disorders: implications for disease management and therapy 50
Add-on rituximab for primary heart involvement associated with systemic sclerosis: A step forward in the tailored treatment of myocarditis? 50
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies 50
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: A report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group 49
La sclerodermia 49
The therapeutic potential of epigenetics in autoimmune diseases 49
Digital ulcers predict a worse disease course in patients with systemic sclerosis 49
Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report 48
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 47
Gastrointestinal symptoms and nutritional profile during pregnancy 47
The geoepidemiology of autoimmune liver disease 46
The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies 46
DRESS syndrome in response to Denosumab: First documented case report 46
How advances in personalized medicine will change rheumatology 46
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 45
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 45
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 44
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature 44
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 43
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy 43
Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate 42
Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology 41
Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis 41
Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis 40
Septic sacroiliitis: an uncommon septic arthritis 40
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 40
Cancer in connective tissue disease 39
The genetic bases of asthma 39
Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis 39
IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy 38
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine 38
Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing 38
Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype 37
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 37
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients 37
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals 37
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis 36
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database 36
Tubercolosi osteoarticolare 36
T and B cells in the skin of systemic sclerosis patients 36
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature 36
Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis 36
Totale 6.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.947
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021335 0 0 0 0 0 96 45 21 74 39 2 58
2021/2022191 12 2 3 42 1 0 9 29 10 17 42 24
2022/20231.628 102 102 151 222 118 150 5 193 289 142 129 25
2023/20241.279 105 102 271 106 35 175 82 33 21 42 80 227
2024/20252.529 47 19 621 42 58 251 159 137 321 448 232 194
2025/20262.483 777 280 612 470 223 121 0 0 0 0 0 0
Totale 8.473